Ranolazine
Ranozek is a medicine used in combination with other medicines to treat angina pectoris, characterized by chest pain or discomfort in the upper body between the neck and the abdomen, often caused by physical exertion or excessive physical activity.
If there is no improvement or the patient feels worse, they should consult a doctor.
Before starting to take Ranozek, you should discuss this with your doctor:
If any of the above situations apply to you, your doctor may decide to use a lower dose or take other precautions.
Tell your doctor or pharmacist about all the medicines you are taking or have recently taken, as well as any medicines you plan to take.
You must not take the following medicines while taking Ranozek:
Tell your doctor or pharmacist before taking Ranozek if you are taking:
Ranozek can be taken with or after a meal. Do not drink grapefruit juice while taking Ranozek.
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor for advice before taking this medicine.
Pregnancy
If your doctor has not prescribed Ranozek, do not take it during pregnancy.
Breastfeeding
Do not take Ranozek while breastfeeding. If you are breastfeeding, ask your doctor for advice.
No studies have been conducted on the effects of Ranozek on the ability to drive or operate machinery. Ask your doctor for advice on driving and using machines.
Ranozek may cause side effects such as dizziness (frequent), blurred vision (uncommon), confusion (uncommon), hallucinations (uncommon), double vision (uncommon), coordination problems (rare), which may affect your ability to drive or operate machinery. If you experience these symptoms, do not drive or operate machinery until they have completely resolved.
Ranozek contains less than 1 mmol of sodium (23 mg) per tablet, which means it is essentially "sodium-free".
Always take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist.
Swallow the tablets whole with water. Do not crush, suck, chew, or divide the tablets, as this may change the special release properties of the tablets in your body.
The initial dose for adults is: one 375 mg tablet twice a day. After 2-4 weeks, your doctor may increase the dose to achieve the desired effect of the medicine. The maximum dose of Ranozek is 750 mg twice a day.
It is important to inform your doctor if you experience side effects such as dizziness, nausea, or vomiting. Your doctor may reduce the dose or stop Ranozek.
Children and adolescents under 18 years of age should not take Ranozek.
If you accidentally take more Ranozek tablets or a higher dose than recommended, tell your doctor immediately. If it is not possible to contact your doctor, go to the nearest hospital emergency department. Take all remaining tablets, including the package and packaging, so that hospital staff can easily identify the medicine taken.
If you miss a dose, take it as soon as possible, unless it is almost time (less than 6 hours) for the next dose. Do not take a double dose to make up for a missed dose.
If you have any further questions about taking this medicine, ask your doctor or pharmacist.
Like all medicines, Ranozek can cause side effects, although not everybody gets them.
Stop taking Ranozek and contact your doctor immediately if you experience the following symptoms of angioedema, which is rare but can be severe:
Tell your doctor if you experience common side effects, such as dizziness, nausea, or vomiting. Your doctor may reduce the dose or stop Ranozek.
Other side effects that may occur include:
Constipation
Dizziness
Headache
Nausea, vomiting
Feeling weak
Changes in sensation
Anxiety, difficulty sleeping, confusion, hallucinations
Blurred vision, vision disturbances
Changes in taste or touch, tremors, feeling tired or slow, drowsiness or somnolence (increased, uncontrollable tendency to fall asleep), feeling faint or fainting, dizziness when standing up
Dark urine, blood in urine, difficulty urinating
Dehydration
Breathing difficulties, cough, nosebleeds
Double vision
Excessive sweating, itching
Feeling bloated or swollen
Sudden flushing of the face, low blood pressure
Increased creatinine or urea levels in the blood, increased platelet or white blood cell count, changes in ECG
Joint swelling, pain in limbs
Loss of appetite and/or weight loss
Muscle cramps, muscle weakness
Ringing in the ears and/or feeling dizzy
Stomach pain or discomfort, indigestion, dry mouth or gas
Difficulty urinating
Abnormal liver function test results
Acute kidney failure
Changes in sense of smell, numbness in the mouth or lips, hearing impairment
Cold sweats, rash
Coordination problems
Low blood pressure when standing up
Loss of consciousness or decreased consciousness
Disorientation
Feeling cold in hands and feet
Hives, allergic skin reactions
Impotence
Walking difficulties due to balance disorders
Pancreatitis or intestinal inflammation
Memory loss
Throat constriction
Low sodium levels in the blood (hyponatremia), which may cause fatigue and confusion, muscle tremors, cramps, and coma.
Side effects with unknown frequency(frequency cannot be estimated from available data):
Clonic muscle spasms.
If you experience any side effects, including any not listed in this leaflet, please tell your doctor or pharmacist.
Side effects can be reported directly to the Department of Adverse Reaction Monitoring of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging after EXP.
The expiry date refers to the last day of the month stated.
There are no special storage instructions for this medicine.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
The active substance of Ranozek is ranolazine. One tablet contains 375 mg, 500 mg, or 750 mg of ranolazine.
The other ingredients are:
Core:Microcrystalline cellulose, type 101, Methacrylic acid and ethyl acrylate copolymer (1:1), Sodium hydroxide, Hypromellose E50, Magnesium stearate.
AquaPolish P white 014.58C coating:Hypromellose E5, Hypromellose E15, Hydroxypropylcellulose, Macrogol 8000, Titanium dioxide (E171)
White, elongated, biconvex, film-coated tablet, 15 mm x 7.2 mm in size, with "375" engraved on one side.
White, elongated, biconvex, film-coated tablet, 16.5 mm x 8.0 mm in size, with "500" engraved on one side.
White, elongated, biconvex, film-coated tablet, 19 mm x 9.2 mm in size, with "750" engraved on one side.
Ranozek is available in cardboard boxes containing 30, 60, or 100 tablets in blisters.
Not all pack sizes may be marketed.
Adamed Pharma S.A.
Pieńków, ul. M. Adamkiewicza 6A,
05-152 Czosnów
Phone: +48 22 732 77 00
Adamed Pharma S.A.
ul. Marszałka Józefa Piłsudskiego 5
95-200 Pabianice
Poland:
Ranozek
Netherlands:
Ranozek 375 mg tabletten met verlengde afgifte
Ranozek 500 mg tabletten met verlengde afgifte
Ranozek 750 mg tabletten met verlengde afgifte
Germany:
Ranozek 375 mg Retardtabletten
Ranozek 500 mg Retardtabletten
Ranozek 750 mg Retardtabletten
Latvia:
Ranozek 375 mg Ilgstošās darbības tablete
Ranozek 500 mg Ilgstošās darbības tablete
Ranozek 750 mg Ilgstošās darbības tablete
Italy:
Ranozek
Spain:
Ranozek 375 mg Comprimido de liberación prolongada EFG
Ranozek 500 mg Comprimido de liberación prolongada EFG
Ranozek 750 mg Comprimido de liberación prolongada EFG
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.